Ike Swetlitz on Muck Rack

Ike Swetlitz

Verified
Boston
As seen in: Bloomberg News, MSN, Bloomberg Green Daily, Business Insider, Fox News, HuffPost, The Guardian, TIME, Yahoo News New Zealand, Yahoo Singapore, Los Angeles Times and
Covers:  environment, yale, new haven, science and the environment, science
I don't check DM's; contact me here: www.ikeswetlitz.com/contact-me Bloomberg @business health reporter in Boston. Previously: @SearchlightNM @statnews

Get in touch with Ike

Contact Ike, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Ike Swetlitz’s Biography

Read Full Bio →

Ike Swetlitz is a student journalist at Yale University. He writes for many student publications, primarily The New Journal and the Yale Daily News. Swetlitz is pursuing a physics degree and is an active leader in Yale's Jewish community.

Ike Swetlitz’s Journalist Portfolio

Against the Tide

Against the Tide

As the water’s edge draws closer, a cozy beach community stands against nature.

View article →
Top of His Glass

Top of His Glass

A journey into scientific glassblowing at Yale.

View article →
Now in 3D

Now in 3D

“This is half a lung.” Mark Michalski held up a twisting piece of plastic, one inch thick, to his chest. To m…

View article →
Pass the Grub

Pass the Grub

Redford ate her first bug–a spider–in kindergarten. Another child who took pleasure in slaughtering spiders r…

View article →
Powered Down

Powered Down

English Station’s complicated history of ownership and contamination includes battles between owners and loca…

View article →

Articles

New Cigna CEO’s patient-first focus to face Wall Street test

|
By John Tozzi Verified, Ike Swetlitz Verified
| Crain's New York Business Verified
Brian Evanko during an interview at Bloomberg's headquarters in New York. (John Lamparski/Photographer: John Lamparski/Blo) JT By John Tozzi and Ike Swetlitz, Bloomberg July 02, 2026 06:00 AM EDT Brian Evanko, Cigna Group’s new chief executive officer, said he aims to put patients at the center of the company’s strategy. He’ll have to convince people struggling with rising healthcare costs that he’s serious — and persuade Wall Street that this strategy can be profitable.
Open in Who Shared Issue with article?

Cigna’s CEO vows to put patients first. Wall Street is watching

|
By John Tozzi Verified, Ike Swetlitz Verified
| Modern Healthcare Verified
Brian Evanko, Cigna Group’s new chief executive officer, said he aims to put patients at the center of the company’s strategy. He’ll have to convince people struggling with rising healthcare costs that he’s serious — and persuade Wall Street that this strategy can be profitable.
Open in Who Shared View Duplicates (4) Issue with article?

Amgen Drug Tavneos’ Main Study Retracted by Medical Journal (1) Original

|
By Ike Swetlitz Verified, Robert Langreth Verified
| Bloomberg Law Verified
A clinical trial used to approve ’s pill Tavneos was retracted Monday from the , putting the drug’s continued sales at risk. Two of the study’s authors requested the retraction, the journal said Monday. The journal cited a US Food and Drug Administration investigation that found the results of nine patients were changed after the study’s database was finalized and some researchers were unblinded, meaning they were told which patients got the experimental drug and which did not.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1,196 licensed articles (1,958 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified